SuperworthOrion EPS OEC
Diluted earnings per share by quarter and over the last twelve months, from 2019.
- Last 12 months, to Jun 30, 2026
- −$1.73
- Latest quarter, Q2 FY26
- $0.03
- −81% on a year earlier
- Fiscal year 2025
- −$1.26
- −268% on the year before
Orion's earnings per share was −$1.73 over the twelve months to Jun 30, 2026, down 741% on a year earlier.
In its latest quarter, Q2 FY26, it was $0.03, down 81% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$1.26 | −268% |
| FY2024 | $0.75 | −57% |
| FY2023 | $1.73 | −1% |
| FY2022 | $1.74 | −22% |
| FY2021 | $2.23 | +643% |
| FY2020 | $0.30 | −79% |
| FY2019 | $1.41 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.03 | −81% | −$1.73 | |
| Q1 FY26 | −$0.18 | −213% | −$1.60 | |
| Q4 FY25 | −$0.38 | −227% | −$1.26 | |
| Q3 FY25 | −$1.20 | n/a | −$0.58 | |
| Q2 FY25 | $0.16 | −54% | $0.27 | |
| Q1 FY25 | $0.16 | −64% | $0.46 | |
| Q4 FY24 | $0.30 | +275% | $0.75 | |
| Q3 FY24 | −$0.35 | −180% | $0.53 | |
| Q2 FY24 | $0.35 | −31% | $1.32 | |
| Q1 FY24 | $0.45 | −36% | $1.48 | |
| Q4 FY23 | $0.08 | −60% | $1.73 | |
| Q3 FY23 | $0.44 | −15% | $1.85 |
Against its peers
Companies in Chemicals nearest Orion's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| OECOrion | −$1.73 | −741% a year |
| NAGENiagen Bioscience | $0.18 | −14% a year |
| FTKFlotek Industries | $0.99 | +125% a year |
| FTLFFitlife Brands | $0.62 | −23% a year |
| CRONCronos | $0.20 | +300% a year |
| ROGRogers | $1.75 | |
| NGVTIngevity | $1.47 | |
| IOSPInnospec | $4.90 | +545% a year |
| BTMDbiote | $0.10 | −89% a year |
| FULFuller H B | $3.59 | +72% a year |
| WDFCWD 40 | $6.58 | +4% a year |
| Peer median | $1.23 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Orion
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.